BACKGROUND: Microglia, the primary immune cells of the brain, are implicated in alcohol use disorder. However, it is not known if microglial activation contributes to the transition from alcohol use to alcohol use disorder or is a consequence of alcohol intake. METHODS: We investigated the role of microglia in a mouse model of alcohol dependence using a colony stimulating factor 1 receptor inhibitor (PLX5622) to deplete microglia and a chronic intermittent ethanol vapor two-bottle choice drinking procedure. Additionally, we examined anxiety-like behavior during withdrawal. We then analyzed synaptic neuroadaptations in the central nucleus of the amygdala (CeA) and gene expression changes in the medial prefrontal cortex and CeA from the same animals used for behavioral studies. RESULTS: PLX5622 prevented escalations in voluntary alcohol intake and decreased anxiety-like behavior associated with alcohol dependence. PLX5622 also reversed expression changes in inflammatory-related genes and glutamatergic and GABAergic (gamma-aminobutyric acidergic) genes in the medial prefrontal cortex and CeA. At the cellular level in these animals, microglia depletion reduced inhibitory GABAA and excitatory glutamate receptor-mediated synaptic transmission in the CeA, supporting the hypothesis that microglia regulate dependence-induced changes in neuronal function. CONCLUSIONS: Our multifaceted approach is the first to link microglia to the molecular, cellular, and behavioral changes associated with the development of alcohol dependence, suggesting that microglia may also be critical for the development and progression of alcohol use disorder.
BACKGROUND: Microglia, the primary immune cells of the brain, are implicated in alcohol use disorder. However, it is not known if microglial activation contributes to the transition from alcohol use to alcohol use disorder or is a consequence of alcohol intake. METHODS: We investigated the role of microglia in a mouse model of alcohol dependence using a colony stimulating factor 1 receptor inhibitor (PLX5622) to deplete microglia and a chronic intermittent ethanol vapor two-bottle choice drinking procedure. Additionally, we examined anxiety-like behavior during withdrawal. We then analyzed synaptic neuroadaptations in the central nucleus of the amygdala (CeA) and gene expression changes in the medial prefrontal cortex and CeA from the same animals used for behavioral studies. RESULTS: PLX5622 prevented escalations in voluntary alcohol intake and decreased anxiety-like behavior associated with alcohol dependence. PLX5622 also reversed expression changes in inflammatory-related genes and glutamatergic and GABAergic (gamma-aminobutyric acidergic) genes in the medial prefrontal cortex and CeA. At the cellular level in these animals, microglia depletion reduced inhibitory GABAA and excitatory glutamate receptor-mediated synaptic transmission in the CeA, supporting the hypothesis that microglia regulate dependence-induced changes in neuronal function. CONCLUSIONS: Our multifaceted approach is the first to link microglia to the molecular, cellular, and behavioral changes associated with the development of alcohol dependence, suggesting that microglia may also be critical for the development and progression of alcohol use disorder.
Authors: Marisa Roberto; Samuel G Madamba; David G Stouffer; Loren H Parsons; George Robert Siggins Journal: J Neurosci Date: 2004-11-10 Impact factor: 6.167
Authors: M Bajo; S E Montgomery; L N Cates; T Nadav; A M Delucchi; K Cheng; H Yin; E F Crawford; A J Roberts; M Roberto Journal: Alcohol Alcohol Date: 2016-05-05 Impact factor: 2.826
Authors: Reesha R Patel; Sophia Khom; Michael Q Steinman; Florence P Varodayan; William B Kiosses; David M Hedges; Roman Vlkolinsky; Tali Nadav; Ilham Polis; Michal Bajo; Amanda J Roberts; Marisa Roberto Journal: Brain Behav Immun Date: 2018-10-26 Impact factor: 7.217
Authors: Christopher N Parkhurst; Guang Yang; Ipe Ninan; Jeffrey N Savas; John R Yates; Juan J Lafaille; Barbara L Hempstead; Dan R Littman; Wen-Biao Gan Journal: Cell Date: 2013-12-19 Impact factor: 41.582
Authors: Michal Bajo; Florence P Varodayan; Samuel G Madamba; Amanda J Robert; Lindsey M Casal; Christopher S Oleata; George R Siggins; Marisa Roberto Journal: Front Pharmacol Date: 2015-03-19 Impact factor: 5.810
Authors: Anna S Warden; Todd A Triplett; Aram Lyu; Emily K Grantham; Moatasem M Azzam; Adriana DaCosta; Sonia Mason; Yuri A Blednov; Lauren I R Ehrlich; R Dayne Mayfield; R Adron Harris Journal: Addict Biol Date: 2020-03-16 Impact factor: 4.093
Authors: Solal Bloch; Katherine M Holleran; Thomas L Kash; Elena M Vazey; Jennifer A Rinker; Christina L Lebonville; Krysten O'Hara; Marcelo F Lopez; Sara R Jones; Kathleen A Grant; Howard C Becker; Patrick J Mulholland Journal: Alcohol Date: 2022-02-15 Impact factor: 2.405
Authors: Yann S Mineur; Vernon Garcia-Rivas; Merrilee A Thomas; Alexa R Soares; Sherry A McKee; Marina R Picciotto Journal: Psychopharmacology (Berl) Date: 2022-03-31 Impact factor: 4.530
Authors: Jennifer K Melbourne; Cassie M Chandler; Catherine E Van Doorn; Michael T Bardo; James R Pauly; Hui Peng; Kimberly Nixon Journal: Alcohol Clin Exp Res Date: 2021-09-05 Impact factor: 3.928
Authors: Lindsay R Meredith; Elizabeth M Burnette; Erica N Grodin; Michael R Irwin; Lara A Ray Journal: Brain Behav Immun Date: 2021-07-31 Impact factor: 19.227